1. Home
  2. TEVA vs CASY Comparison

TEVA vs CASY Comparison

Compare TEVA & CASY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • CASY
  • Stock Information
  • Founded
  • TEVA 1901
  • CASY 1959
  • Country
  • TEVA Israel
  • CASY United States
  • Employees
  • TEVA N/A
  • CASY N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • CASY Diversified Commercial Services
  • Sector
  • TEVA Health Care
  • CASY Miscellaneous
  • Exchange
  • TEVA Nasdaq
  • CASY Nasdaq
  • Market Cap
  • TEVA 20.1B
  • CASY 19.6B
  • IPO Year
  • TEVA N/A
  • CASY N/A
  • Fundamental
  • Price
  • TEVA $16.05
  • CASY $510.25
  • Analyst Decision
  • TEVA Strong Buy
  • CASY Buy
  • Analyst Count
  • TEVA 7
  • CASY 13
  • Target Price
  • TEVA $24.71
  • CASY $461.00
  • AVG Volume (30 Days)
  • TEVA 9.9M
  • CASY 306.9K
  • Earning Date
  • TEVA 07-30-2025
  • CASY 09-03-2025
  • Dividend Yield
  • TEVA N/A
  • CASY 0.45%
  • EPS Growth
  • TEVA N/A
  • CASY 9.01
  • EPS
  • TEVA N/A
  • CASY 14.64
  • Revenue
  • TEVA $16,616,000,000.00
  • CASY $15,940,899,000.00
  • Revenue This Year
  • TEVA $5.69
  • CASY $11.09
  • Revenue Next Year
  • TEVA N/A
  • CASY $5.70
  • P/E Ratio
  • TEVA N/A
  • CASY $34.73
  • Revenue Growth
  • TEVA 3.82
  • CASY 7.25
  • 52 Week Low
  • TEVA $12.47
  • CASY $350.52
  • 52 Week High
  • TEVA $22.80
  • CASY $526.82
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 40.10
  • CASY 54.14
  • Support Level
  • TEVA $15.82
  • CASY $514.12
  • Resistance Level
  • TEVA $16.74
  • CASY $526.72
  • Average True Range (ATR)
  • TEVA 0.38
  • CASY 10.63
  • MACD
  • TEVA -0.08
  • CASY -2.62
  • Stochastic Oscillator
  • TEVA 15.54
  • CASY 38.65

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About CASY Casey's General Stores Inc.

Casey's General Stores Inc serves as the nation's third-largest convenience store chain with its 2,900 locations, positioned in the Midwest United States. About half of Casey's stores are located in rural towns with populations under 5,000. While fueling stations serve as a key traffic driver, about two-thirds of the company's gross profit stems from in-store sales of grocery items, prepared meals, and general merchandise. Casey's owns more than 90% of its stores and operates the majority of its warehousing and distribution processes internally.

Share on Social Networks: